Tolion Health AI Appoints Global Health & AI Leader Gregory J. Moore, MD, PhD, to Board of Directors

Key Terms

artificial intelligence technical

Artificial intelligence is the ability of computers and machines to perform tasks that typically require human thinking, such as understanding language, recognizing patterns, or making decisions. For investors, it matters because AI can enhance efficiency, uncover new insights, and enable smarter strategies, potentially impacting the value and performance of companies that develop or utilize this technology.

neuroradiologist medical

A neuroradiologist is a medical specialist who reads and interprets images of the brain, spinal cord and nearby nerves using scans such as MRI and CT, and advises on diagnosis and treatment. For investors, their role matters because their interpretations and demand for advanced imaging drive sales and adoption of imaging equipment, influence the pace and success of clinical trials for neurological drugs or devices, and affect hospital service revenue—similar to how a forensic photo analyst guides decisions based on visual evidence.

clinical informatics medical

Clinical informatics organizes and analyzes medical and patient data using software, databases and tools so clinicians can make faster, safer decisions—think of it as a traffic-control system and smart filing cabinet for healthcare information. Investors care because these systems drive adoption of digital tools, reduce errors and costs, help providers meet regulatory requirements, and create recurring revenue opportunities for companies that sell or host the technology.

regulatory readiness regulatory

Regulatory readiness is how prepared a company, product or project is to meet the laws, approvals and inspections required by government agencies. Investors care because greater readiness lowers the chance of costly delays, rework or fines and makes timing and costs more predictable—like having all travel documents and bags packed correctly before a flight, which cuts the risk of being held up at the airport.

Former Microsoft and Google Health Executive Strengthens Board Leadership, Product Development, Regulatory Preparedness, and Global Expansion

Tolion Brain Coach Assists Users in Identifying and Managing Modifiable Risk Factors Associated with Cognitive Health and Performance

Free AI-Powered Mobile App on Apple App Store Helps Millions at Risk for Alzheimer’s Manage Their Brain Health

Lifestyle Choices and Prevention Seen as Key Factors in Lowering Dementia Risk for Individuals

BOSTON--(BUSINESS WIRE)-- Tolion Health AI, a digital health company developing artificial intelligence solutions for personalized, predictive, and preventive brain-health guidance, today announced the appointment of Gregory J. Moore, MD, PhD, to its Board of Directors. Dr. Moore brings experience as a physician-scientist, neuroradiologist, engineer, and healthcare technology leader, having overseen global teams at both Microsoft and Google where he applied AI and data platforms across healthcare and life sciences. Dr. Moore’s appointment reinforces Tolion’s commitment to uniting clinical expertise with cutting-edge technology to drive innovation in preventive brain health.

Tolion Health AI Appoints Global Health & AI Leader Gregory J. Moore, MD, PhD, to Board of Directors

“2025 was a transformative year for Tolion, with the US launch of Tolion Brain Coach, successful fundraising, and infrastructure growth in the US and Europe. As we commercialize our flagship product, Greg’s appointment highlights Tolion’s focus on combining clinical expertise with technology to advance preventive brain health,” said Martin Tolar, MD, PhD, Founder and Executive Chairman of Tolion Health AI. “Greg has been a valuable partner and trusted friend in building Tolion, contributing to strategic planning and product analysis with our leadership teams. His background as a physician, technologist, and board director will help us refine our strategy, boost operational excellence, and support responsible, global growth in evidence-based preventive brain care.”

In November 2025, Tolion introduced Tolion Brain Coach on the Apple App Store, offering an AI-powered preventive solution integrated with Garmin technology. Looking ahead to 2026, the company intends to drive user growth, enhance interoperability, including integration with Apple Health and release of an Android application, and strengthen collaborations with laboratories, health plans, as well as concierge and specialty care providers.

“Tolion is a leading AI-first platform for early prevention in cognitive decline with a clear focus on what matters most: translating credible science into daily, achievable actions that can improve brain health over time and prevent cognitive decline,” said Gregory J. Moore, MD, PhD. “I am excited to join the Board and support the team as they scale, ensuring clinical validity, privacy, security, and regulatory readiness, to build trust and achieve global impact. Tolion’s practical medical guidance can change our approach to brain health. The best time for prevention was years ago; with Tolion, it's possible now!"

Leadership Excellence in Health AI and Digital Health
Dr. Moore previously held the position of Corporate Vice President at Microsoft Health & Life Sciences, directing global R&D strategy, engineering, and product teams dedicated to advancing AI and data platform applications within healthcare and life sciences. Before joining Microsoft, he served as Vice President at Google and founded the Google Cloud Healthcare & Life Sciences division, where he established and expanded Google’s worldwide health and life sciences operations. Dr. Moore's notable contributions have played a significant role in the widespread adoption of advanced cloud technologies and strategic data methodologies, facilitating the integration of sophisticated AI and data-driven solutions into medical practice, and setting new benchmarks for healthcare systems and life sciences organizations.

Dr. Moore currently serves on the boards of DaVita Inc. (NYSE: DVA) and Fortive Corporation (NYSE: FTV), acts as Senior Advisor to Gates Ventures for Alzheimer’s Disease initiatives involving AI and data, and provides guidance to various other projects in the AI, healthcare, and life sciences sectors. Dr. Moore is board-certified in Diagnostic Radiology, Neuroradiology, and Clinical Informatics, and has held clinical and academic appointments at Stanford, Penn State, and Wayne State University. He received his MD from Wayne State University School of Medicine and earned his PhD in Radiological Sciences from MIT.

Board Priorities: Scale, Compliance, Impact
Dr. Moore’s appointment strengthens Tolion’s focus on combining clinical expertise with advanced technology for preventive brain health. His leadership will keep Tolion’s efforts practical, evidence-based, ethical, and privacy-conscious.

As a director, Dr. Moore will help guide Tolion’s strategy in several key areas:

• Overseeing regulatory and quality efforts, particularly those related to accurate product claims and proper validation.
• Enhancing technology and security measures to enable tailored recommendations and seamless data exchange.
• Advancing Tolion Brain Age as a health motivation tool and a means of increasing user engagement.
• Supporting global growth and partnership initiatives, especially targeting markets in the U.S., Europe and Japan.
• Shaping business development plans and channel strategies.

About Tolion Brain Coach
Tolion Brain Coach is an AI-powered app designed to support brain health, performance, and longevity. Using the proprietary Tolion AI Engine, which combines knowledge management, machine learning, and large language model, it offers daily recommendations grounded in scientific research. The app addresses modifiable risk factors and provides tools for cognitive well-being.

By integrating medical brain health insights with user data, Tolion’s products aim to boost brain health and lower neurodegenerative risks, such as Alzheimer’s, via prevention. Since up to 45% of dementia cases may be preventable through lifestyle changes, the app helps users improve sleep, manage stress, stay active, and engage their minds.

The Tolion Brain Coach mobile app delivers personalized guidance through features such as:

• Personalized Risk Insights: AI analyzes your lifestyle, behavior, and environment, including sleep and activity.
• Wearable Integration: Syncs instantly with Garmin devices for live sleep tracking.
• Weekly Brain Health Planner: Micro-goals and coaching plans support healthy routines.
• Progress Tracking: Dashboards show consistency and long-term progress.
• Conversational Brain Coach: In-app AI offers empathetic, motivational guidance.
• Brain Age Score: Calculates brain’s biological age from lifestyle, genetic, and biomarker data.

Tolion Brain Coach can be downloaded from the Apple App Store. Android and more wearables support will be available in 2026.

Webinars for High-Risk Groups
Tolion Health AI will host online webinars to educate participants on brain health, dementia prevention, and the benefits of the Tolion Brain Coach app for personalized care. Registration is available at Tolion Brain Coach Webinar.

About Tolion Health AI
Tolion Health AI is a digital health company using AI, data, and collaborative technologies to deliver personalized, preventive, and predictive care. With support from medical experts, Tolion integrates advanced technology with insights that help patients manage their health and improve performance. The proprietary Tolion MedPortal and Tolion AI Engine identify and address key brain health risk factors, aiming to enhance quality of life and longevity. Tolion MedPortal manages vast medical data using AI to refine the company's knowledge base, while the Tolion AI Engine offers customized health guidance based on genetics, history, and medical status. The innovative Tolion Brain Coach mobile app provides users with access to extensive medical expertise, supporting early prevention, accurate diagnosis, and continuous care for better health outcomes.

Follow Tolion on LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260106738130/en/

Media Contact

Tereza Kulhánková

+420 731 142 109

tereza.kulhankova@tolion.com

Investor Contact

Petr Zmatlo

+420 603 861 377

petr.zmatlo@tolion.com

Source: Tolion Health AI